[The practice of using a domestic antiviral drug in the etiotropic therapy of acute respiratory viral infection].

Dmitriy A Lioznov I I Tokin T G Zubkova P V Sorokin

Published in: Terapevticheskii arkhiv (2020)

As a result of clinical study, the effectiveness of both ARVI treatment regimens with drug riamilovir has been shown. There were no differences in the effectiveness and safety of the proposed treatment regimens. Practical use of both treatment regimens is recommended. However, according to the authors, taking the drug 3 times a day is much more convenient for patients, improves the quality of life and adherence to therapy.

Keyphrases

healthcare
primary care
randomized controlled trial
emergency department
stem cells
end stage renal disease
drug induced
clinical trial
intensive care unit
ejection fraction
metabolic syndrome
prognostic factors
hepatitis b virus
respiratory failure
weight loss
electronic health record